Kymera Therapeutics shares are trading higher after B of A Securities raised its price target on the stock from $110 to $125.
Kymera Therapeutics shares are trading higher after B of A Securities raised its price target on the stock from $110 to $125.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.